Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Max Schlaak

Showing results (31-40 of 98) with videos related to

Pageof 10
Sort By:
Frontiers in Oncology|March 5, 2019
Successful Treatment of Myasthenia Gravis Following PD-1/CTLA-4 Combination Checkpoint Blockade in a Patient With Metastatic MelanomaJan-Michael Werner, Viola Schweinsberg, Michael Schroeter, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 17, 2022
Chlormethin-Gel zur Behandlung der Mycosis fungoides: Ein Expertenkonsens aus Deutschland, Österreich und der Schweiz (DACH-Region) zum TherapiemanagementChalid Assaf, Nina Booken, Edgar Dippel, et al.
European Radiology|October 17, 2018
Precision and reliability of liver iodine quantification from spectral detector CT: evidence from phantom and patient dataNils Große Hokamp, Nuran Abdullayev, Thorsten Persigehl, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|April 16, 2022
The optimal use of chlormethine gel for mycosis fungoides: An expert consensus from Germany, Austria and Switzerland (DACH region)Chalid Assaf, Nina Booken, Edgar Dippel, et al.
BMC Cancer|January 14, 2014
Comparison of high resolution melting analysis, pyrosequencing, next generation sequencing and immunohistochemistry to conventional Sanger sequencing for the detection of p.V600E and non-p.V600E BRAF mutationsMichaela Angelika Ihle, Jana Fassunke, Katharina König, et al.
Immunotherapy|March 31, 2017
Short review of potential synergies of immune checkpoint inhibition and radiotherapy with a focus on Hodgkin lymphoma: radio-immunotherapy opens new doorsChristian Baues, Maike Trommer-Nestler, Karolina Jablonska, et al.
Journal for Immunotherapy of Cancer|June 17, 2018
Cytokine release syndromeAlexander Shimabukuro-Vornhagen, Philipp Gödel, Marion Subklewe, et al.
European Journal of Radiology|July 28, 2020
Evaluating body composition by combining quantitative spectral detector computed tomography and deep learning-based image segmentationDavid Zopfs, Khaled Bousabarah, Simon Lennartz, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|January 16, 2020
[Personalized medicine in the treatment of periocular tumors : Targeted treatment and use of immune checkpoint inhibitors]Alexander C Rokohl, Konrad R Koch, Joel M Mor, et al.
Blood|July 28, 2012
Mast cells play a protumorigenic role in primary cutaneous lymphomaAnja Rabenhorst, Max Schlaak, Lukas C Heukamp, et al.
Pageof 10

Showing results (31-40 of 98) with videos related to

Sort By:
Pageof 10
Frontiers in Oncology|March 5, 2019
Successful Treatment of Myasthenia Gravis Following PD-1/CTLA-4 Combination Checkpoint Blockade in a Patient With Metastatic MelanomaJan-Michael Werner, Viola Schweinsberg, Michael Schroeter, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 17, 2022
Chlormethin-Gel zur Behandlung der Mycosis fungoides: Ein Expertenkonsens aus Deutschland, Österreich und der Schweiz (DACH-Region) zum TherapiemanagementChalid Assaf, Nina Booken, Edgar Dippel, et al.
European Radiology|October 17, 2018
Precision and reliability of liver iodine quantification from spectral detector CT: evidence from phantom and patient dataNils Große Hokamp, Nuran Abdullayev, Thorsten Persigehl, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|April 16, 2022
The optimal use of chlormethine gel for mycosis fungoides: An expert consensus from Germany, Austria and Switzerland (DACH region)Chalid Assaf, Nina Booken, Edgar Dippel, et al.
BMC Cancer|January 14, 2014
Comparison of high resolution melting analysis, pyrosequencing, next generation sequencing and immunohistochemistry to conventional Sanger sequencing for the detection of p.V600E and non-p.V600E BRAF mutationsMichaela Angelika Ihle, Jana Fassunke, Katharina König, et al.
Immunotherapy|March 31, 2017
Short review of potential synergies of immune checkpoint inhibition and radiotherapy with a focus on Hodgkin lymphoma: radio-immunotherapy opens new doorsChristian Baues, Maike Trommer-Nestler, Karolina Jablonska, et al.
Journal for Immunotherapy of Cancer|June 17, 2018
Cytokine release syndromeAlexander Shimabukuro-Vornhagen, Philipp Gödel, Marion Subklewe, et al.
European Journal of Radiology|July 28, 2020
Evaluating body composition by combining quantitative spectral detector computed tomography and deep learning-based image segmentationDavid Zopfs, Khaled Bousabarah, Simon Lennartz, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|January 16, 2020
[Personalized medicine in the treatment of periocular tumors : Targeted treatment and use of immune checkpoint inhibitors]Alexander C Rokohl, Konrad R Koch, Joel M Mor, et al.
Blood|July 28, 2012
Mast cells play a protumorigenic role in primary cutaneous lymphomaAnja Rabenhorst, Max Schlaak, Lukas C Heukamp, et al.
Pageof 10